In 2023, an estimated 13% of worldwide deaths resulting from antimicrobial resistance (AMR) were due to drug-resistant TB (DR-TB). The World Health Organization (WHO) documented a dramatic, sixfold increase in the number of patients treated with 6-month all-oral (BPaLM) regimens, from 5,653 patients in 2023, to 34,00...
Ming-Xiao Yao, Bo Pang, Ling Tian et al.· Frontiers in Immunology· 0 citations
An in-depth examination of the molecular epidemiology, clinical characteristics, and the seasonal and geographic distribution of dengue cases in China from 2005 to 2023 is offered.
Kun Peng, Xiao-Dan Huang, Peng-Xiang Huang et al.· Frontiers in Cellular and In...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.